Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Antimicrobial Agents and Chemotherapy|August 1, 1993
Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulinH C Meissner, D R Fulton, J R Groothuis, et al.
The Journal of Pediatrics|November 1, 1990
Early ribavirin treatment of respiratory syncytial viral infection in high-risk childrenJ R Groothuis, K A Woodin, R Katz, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study GroupJ R Groothuis, M J Levin, W Rodriguez, et al.
The Journal of Pediatrics|July 1, 1994
Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trialW J Rodriguez, C B Hall, R Welliver, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulinJ R Groothuis, E A Simoes, M V Lehr, et al.
The New England Journal of Medicine|November 18, 1993
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study GroupJ R Groothuis, E A Simoes, M J Levin, et al.
Pediatrics|March 1, 1997
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study GroupW J Rodriguez, W C Gruber, R C Welliver, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV diseaseH C Meissner, J R Groothuis, W J Rodriguez, et al.
Pageof 5